Skip to main content

Patient Compliance

  • Tic Talk

    What pharmacists should know when caring for patients with Tourette syndrome.
  • Spotlight: Lighting a spark in the profession

    Susan Beresford juggles involvement in six professional bodies, in addition to her full-time job as dispensary manager.
  • Ontarians trust pharmacists most for drug info

    Ontarians view their pharmacists as the most trustworthy sources of information about prescription drugs, according to a new survey by Ipsos Reid.
  • Managing statin-induced myalgia

    Muscle symptoms are the most prevalent and important adverse effects associated with stain therapy, and often result in suboptimal adherence.
  • Catena for Friedreich's ataxia

    Santhera Pharmaceuticals is introducing Catena for the symptomatic management of patients with Friedreich's ataxia, which is a rare, progressive neuromuscular disease.
  • Tasigna for chronic myeloid leukemia

    In October, Novartis expects to launch Tasigna for the treatment of chronic myeloid leukemia in adults who have developed resistance or intolerance to at least one prior therapy, including imatinib.
  • Xarelto: new oral anticoagulant

    Bayer's Xarelto (rivaroxaban 10 mg tablets) is the second new oral anticoagulant to be marketed in Canada this year, following the introduction of Boehringer Ingelheim's Pradax (dabigatran etexilate 75 mg and 110 mg capsules) in July.
  • Managing milk protein allergy in infants

    Cow's milk protein allergy is the most common form of milk protein allergy, occurring in 2-5% of formula-fed babies and 0.4-0.5% of breastfed babies.
X
This ad will auto-close in 10 seconds